Return to article list

DePuy Synthes Announces Financing Options for the Hana® Orthopedic Surgery Table

New offering helps with investment to aid start-up cost for table used in anterior approach to hip replacement surgery

DECEMBER 13, 2017, Warsaw, Indiana – As an industry leader in the Anterior Approach, today DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies, announced a partnership with Johnson & Johnson Finance Corporation (JJFC) to help healthcare systems accommodate costs associated with the Hana® Orthopedic Surgery Table. The Hana® table allows precise control of patient positioning, manipulation and traction during this minimally invasive hip replacement surgery and provides better access to the hip joint for improved alignment and positioning of the implant.

Healthcare providers and patients alike are realizing the benefits of the Anterior Approach due to its potential to improve costs, optimize the patient experience, and reduce the overall cost of care1-11.

“We continue to find new ways to help hospitals and Ambulatory Surgical Centers (ASCs) adopt the Anterior Approach,” said Polly Teevan, Director of Hip and Shoulder Marketing, DePuy Synthes North America. “We realize the purchase of a Hana® table is a significant capital investment and this offering is the latest in our continued commitment to support healthcare providers with ways in which they can bring the Anterior Approach to their patients.”

Hana Orthopaedic Surgery Table - Used in Anterior Approach to Hip Replacement Surgery

DePuy Synthes has spent more than a decade supporting healthcare providers who are interested in adding the Anterior Approach to their practices. Since 2004, DePuy Synthes has worked closely with Dr. Joel Matta** to provide training as part of the company’s professional education offering. To date, the company has trained more than 11,000 surgeons on the Anterior Approach.

DePuy Synthes also recently launched the ACTIS® Hip, the first DePuy Synthes hip stem specifically designed to be utilized with tissue sparing approaches, such as the Anterior approach. Additionally, two exclusive co-marketing agreements were provided for Medical Enterprises Distribution, LLC’s ME1000™ Impactor and JointPoint’s proprietary software platform, both of which integrate with Anterior Approach to support the goal of reducing the learning curve and increasing reproducibility.

JJFC provides flexible and competitive finance programs to accommodate the clinical and budgetary challenges healthcare systems face every day. The financing option is being rolled out nationwide this month.

The Hana® Orthopedic Surgery Tableis manufactured and distributed through Mizuho OSI® and is showcased at all DePuy Synthes Anterior Approach learning centers.

Visit http://www.mizuhosi.com/products/orthopedic-fracture-trauma/hana/ for information on the Hana® Orthopedic Surgery Table and a DePuy Synthes sales consultant for information on the JJFC financing options.


About DePuy Synthes
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies***, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.


  1. Barrett WP, et al. “Prospective Randomized Study of Direct Anterior vs Postero-Lateral Approach for Total Hip Arthroplasty.” The Journal of Arthroplasty 2013; (28): 1634-1638.
  2. Zawadsky MW, et al. “Early Outcome Comparison Between the Direct Anterior Approach and the Mini-Incision Posterior Approach for Primary Total Hip Arthroplasty: 150 Consecutive Cases.” The Journal of Arthroplasty 2014; (29): 1256-1260.
  3. Christensen CP, et al. “Comparison of Patient Function during the First Six Weeks after Direct Anterior or Posterior Total Hip Arthroplasty (THA): A Randomized Study.” The Journal of Arthroplasty 2015; (30): 94-97.
  4. Petis SM, et al. “In Hospital Cost Analysis of THA: Does Surgical Approach Matter?” The Journal of Arthroplasty 2016; (31)” 53-58.
  5. Martin CT, et al. “A Comparison of Hospital Length of Stay and Short-term Morbidity Between the Anterior and the Posterior Approaches to Total Hip Arthroplasty.” The Journal of Arthroplasty 2013; (28): 849-854.
  6. Alecci V, et al. “Comparison of primary total hip replacements performed with a direct anterior approach versus the standard lateral approach: perioperative findings” J Orthopaed Traumatol 2010.
  7. Higgins BT, et al. 2015. JOA. “Anterior vs. posterior approach for THA, a systematic review and meta-analysis.” The Journal of Arthroplasty 2015; (30): 419–434.
  8. Restrepo C, et al. “Prospective Randomized Study of Two Surgical Approaches for Total Hip Arthroplasty.” The Journal of Arthroplasty 2010; (25(5)): 671-679.
  9. Rodriguez JA, et al. “Does the Direct Anterior Approach in THA Offer Faster Rehabilitation and Comparable Safety to the Posterior Approach?” Clin Orthop Relat Res 2013.
  10. Vail TP, et al. “Approaches in Primary THA.” The Journal of Bone and Joint Surgery 2009; (91): 10-12.
  11. Bourne MH, et al. “A comparison between direct anterior surgery of the hip (DASH) and the anterolateral (AL) surgical approach to THA: Postoperative outcomes.” 2010 AAOS New Orleans, LA, Poster #014.

*DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.
**Dr. Matta is a consultant to DePuy Synthes Joint Reconstruction, and receives royalties as the designer of the Hana® table which is manufactured by Mizuho OSI.
***The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, and cardiovascular businesses within Johnson & Johnson's Medical Devices segment.

©DePuy Synthes 2017. All rights reserved.
Mizuho OSI® and Hana® are registered trademarks of Mizuho OSI.
The third party trademarks used herein are the trademarks of their respective owners.

Filed under: Tagged: